Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sri Pada Datta Chigurupati

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Drug Discovery Today|April 8, 2026
Addressing delivery and resistance issues of CDK4/6 inhibitors as cancer therapeuticsKshitiz Luthra, Nalla Usha Kumari, Sri Pada Datta Chigurupati, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 22, 2025
Pre-programming the protein corona: From avoidance to endogenous targetingNalla Usha Kumari, Sri Pada Datta Chigurupati, Naveen Rajana, et al.
Nanomedicine (London, England)|August 6, 2024
Nanomedicine for colon-targeted drug delivery: strategies focusing on inflammatory bowel disease and colon cancerAnkaj Kumar, Klaudi K Vaiphei, Naveen Singh, et al.
ACS Applied Bio Materials|April 27, 2026
Uveitis Management at the Crossroads of Pharmacotherapy, Nanotechnology, and Intellectual PropertyAayushi Pandey, Rohit Bhawale, Ravindra Vasave, et al.
International Journal of Biological Macromolecules|January 26, 2025
Fabrication and characterization of teriflunomide-loaded chondroitin sulfate hybridized zein nanoparticles for the management of triple negative breast cancerNaveen Rajana, Lakshmi Tulasi Naraharisetti, Nalla Usha Kumari, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Drug Discovery Today|April 8, 2026
Addressing delivery and resistance issues of CDK4/6 inhibitors as cancer therapeuticsKshitiz Luthra, Nalla Usha Kumari, Sri Pada Datta Chigurupati, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 22, 2025
Pre-programming the protein corona: From avoidance to endogenous targetingNalla Usha Kumari, Sri Pada Datta Chigurupati, Naveen Rajana, et al.
Nanomedicine (London, England)|August 6, 2024
Nanomedicine for colon-targeted drug delivery: strategies focusing on inflammatory bowel disease and colon cancerAnkaj Kumar, Klaudi K Vaiphei, Naveen Singh, et al.
ACS Applied Bio Materials|April 27, 2026
Uveitis Management at the Crossroads of Pharmacotherapy, Nanotechnology, and Intellectual PropertyAayushi Pandey, Rohit Bhawale, Ravindra Vasave, et al.
International Journal of Biological Macromolecules|January 26, 2025
Fabrication and characterization of teriflunomide-loaded chondroitin sulfate hybridized zein nanoparticles for the management of triple negative breast cancerNaveen Rajana, Lakshmi Tulasi Naraharisetti, Nalla Usha Kumari, et al.
Pageof 1